海南海藥(000566)9月(yue)13日(ri)晚公(gong)(gong)告,公(gong)(gong)司(si)(si)原本擬收購(gou)海口奇力制藥股份有限公(gong)(gong)司(si)(si)100%股權(quan)。鑒于(yu)近期(qi)醫藥行業(ye)并購(gou)市(shi)場(chang)發生較大(da)變化,公(gong)(gong)司(si)(si)與交(jiao)易對方(fang)對標的公(gong)(gong)司(si)(si)估值未最(zui)終(zhong)達成一致(zhi),不(bu)利于(yu)本次交(jiao)易的推進,決定終(zhong)止本次重(zhong)大(da)資產重(zhong)組事項。海南海藥同時公(gong)(gong)告,公(gong)(gong)司(si)(si)與中(zhong)(zhong)國(guo)國(guo)信信息(xi)總公(gong)(gong)司(si)(si)近日(ri)簽署合(he)作框(kuang)架協議(yi),雙方(fang)擬在醫藥大(da)健康、中(zhong)(zhong)藥材種(zhong)植、加工、中(zhong)(zhong)西藥銷(xiao)售等方(fang)面開展全方(fang)位合(he)作。